Literature DB >> 16272460

TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis.

Stephen K Frankel1, Gregory P Cosgrove, Seung-Ick Cha, Carlyne D Cool, Murry W Wynes, Benjamin L Edelman, Kevin K Brown, David W H Riches.   

Abstract

Pulmonary accumulation of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis/usual interstitial pneumonia (IFP/UIP) has been linked to (1) increased migration of a circulating pool of fibrocytes, (2) cell proliferation, and (3) resistance to apoptosis. The mechanism of physiologic apoptosis of lung fibroblasts is poorly understood. Using normal and fibrotic human lung fibroblasts and the human lung fibroblast cell line, MRC-5, we examined the regulation of Fas-induced apoptosis by the proinflammatory cytokines TNF-alpha and IFN-gamma. Herein, we show that the basal resistance of lung fibroblasts and myofibroblasts to Fas-induced apoptosis is overcome by sensitization with TNF-alpha. IFN-gamma did not sensitize cells to Fas-induced apoptosis, but exhibited synergistic activity with TNF-alpha. Sensitization by TNF-alpha was observed in MRC-5 cells and in fibroblasts and myofibroblasts from normal and fibrotic human lung, suggesting that this represents a conserved mechanism to engage Fas-induced apoptosis. The mechanism of sensitization was localized at the level of recruitment of the adapter protein, FADD, to the cytoplasmic domain of Fas. Collectively, these findings suggest that fibroblast apoptosis involves two steps, sensitization and induction, and that inadequate pulmonary inflammation in IPF/UIP may favor fibroblast accumulation by reducing sensitization to apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16272460      PMCID: PMC2644194          DOI: 10.1165/rcmb.2005-0155OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  61 in total

1.  Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation.

Authors:  J L Cheshire; A S Baldwin
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

2.  Diversity, topographic differentiation, and positional memory in human fibroblasts.

Authors:  Howard Y Chang; Jen-Tsan Chi; Sandrine Dudoit; Chanda Bondre; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-24       Impact factor: 11.205

3.  Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease.

Authors:  J A Martinez; T E King; K Brown; C A Jennings; L Borish; R L Mortenson; T Z Khan; T W Bost; D W Riches
Journal:  Am J Physiol       Date:  1997-09

4.  Phosphorylation of FADD/MORT1 and Fas by kinases that associate with the membrane-proximal cytoplasmic domain of Fas.

Authors:  N J Kennedy; R C Budd
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

5.  Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas.

Authors:  Y Nambu; S J Hughes; A Rehemtulla; D Hamstra; M B Orringer; D G Beer
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

6.  Expression of bcl-2 protein and APO-1 (Fas antigen) in the lung tissue from patients with idiopathic pulmonary fibrosis.

Authors:  M Kazufumi; N Sonoko; K Masanori; I Takateru; O Akira
Journal:  Microsc Res Tech       Date:  1997-09-01       Impact factor: 2.769

7.  Resistance of TNF/LT alpha double deficient mice to bleomycin-induced fibrosis.

Authors:  P F Piguet; S Kaufman; C Barazzone; M Muller; B Ryffel; H P Eugster
Journal:  Int J Exp Pathol       Date:  1997-02       Impact factor: 1.925

8.  Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice.

Authors:  N Hagimoto; K Kuwano; Y Nomoto; R Kunitake; N Hara
Journal:  Am J Respir Cell Mol Biol       Date:  1997-01       Impact factor: 6.914

9.  Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.

Authors:  J Zhang; D Cado; A Chen; N H Kabra; A Winoto
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

10.  Repression of bleomycin-induced pneumopathy by TNF.

Authors:  Misuzu Kuroki; Yuji Noguchi; Michihide Shimono; Kazunori Tomono; Takayoshi Tashiro; Yuichi Obata; Eiichi Nakayama; Shigeru Kohno
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

View more
  41 in total

1.  Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.

Authors:  Jeffrey C Horowitz; Iyabode O Ajayi; Priya Kulasekaran; David S Rogers; Joshua B White; Sarah K Townsend; Eric S White; Richard S Nho; Peter D R Higgins; Steven K Huang; Thomas H Sisson
Journal:  Int J Biochem Cell Biol       Date:  2011-10-25       Impact factor: 5.085

2.  Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection.

Authors:  Daniela Damjanovic; Maziar Divangahi; Kapilan Kugathasan; Cherrie-Lee Small; Anna Zganiacz; Earl G Brown; Cory M Hogaboam; Jack Gauldie; Zhou Xing
Journal:  Am J Pathol       Date:  2011-10-14       Impact factor: 4.307

3.  Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts.

Authors:  Yan Y Sanders; Pallavi Kumbla; James S Hagood
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-07       Impact factor: 6.914

Review 4.  Muscle fatigue: MK2 signaling and myofibroblast differentiation.

Authors:  James S Hagood; Mitchell A Olman
Journal:  Am J Respir Cell Mol Biol       Date:  2007-11       Impact factor: 6.914

5.  Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.

Authors:  Elizabeth F Redente; Rebecca C Keith; William Janssen; Peter M Henson; Luis A Ortiz; Gregory P Downey; Donna L Bratton; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

6.  Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.

Authors:  Alison Bamberg; Elizabeth F Redente; Steve D Groshong; Rubin M Tuder; Carlyne D Cool; Rebecca C Keith; Benjamin L Edelman; Bart P Black; Gregory P Cosgrove; Murry W Wynes; Douglas Curran-Everett; Stijn De Langhe; Luis A Ortiz; Andrew Thorburn; David W H Riches
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

7.  Differential role of the Fas/Fas ligand apoptotic pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome.

Authors:  Andrea D Lopez; Sreedevi Avasarala; Suman Grewal; Anuradha K Murali; Lucille London
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

8.  Tumour necrosis factor-alpha processing in interstitial lung disease: a potential role for exogenous proteinase-3.

Authors:  L Armstrong; S I H Godinho; K M Uppington; H A Whittington; A B Millar
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

9.  X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis.

Authors:  Iyabode O Ajayi; Thomas H Sisson; Peter D R Higgins; Adam J Booth; Rommel L Sagana; Steven K Huang; Eric S White; Jessie E King; Bethany B Moore; Jeffrey C Horowitz
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

10.  Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation.

Authors:  Priya Kulasekaran; Casey A Scavone; David S Rogers; Douglas A Arenberg; Victor J Thannickal; Jeffrey C Horowitz
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-02       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.